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This article describes an improved pooled open reading frame (ORF) expression technology (POET) that uses recombinational
cloning and solution-based tandem mass spectrometry (MS/MS) to identify ORFs that yield high levels of soluble, purified protein
when expressed in Escherichia coli. Using this method, three identical pools of 512 human ORFs were subcloned, purified, and
transfected into three separate E. coli cultures. After bulk expression and purification, the proteins from the three separate pools
were digested into tryptic peptides. Each of these samples was subsequently analyzed in triplicate using reversed-phase high-performance liquid chromatography (LC) coupled directly online with MS/MS. The abundance of each protein was determined by calculating the average exponentially modified protein abundance index (emPAI) of each protein across the three protein pools. Human
proteins that consistently gave high emPAI values were subjected to small-scale expression and purification. These clones showed
high levels of expression of soluble protein. Conversely, proteins that were not observed by LC-MS/MS did not show any detectable
soluble expression in small-scale validation studies. Using this improved POET method allows the expression characteristics of
hundreds of proteins to be quickly determined in a single experiment.

INTRODUCTION
While sequencing of the human
genome has obviously been a major
benefit to genomics, it has also opened
a number of research opportunities
in proteomics: thousands of open
reading frames (ORFs) can now be
cloned and expressed as proteins (1).
Significant efforts have been devoted
to converting these clones into
soluble, purified proteins that can be
used for structural studies (2,3). There
are presently a number of structural
proteomics initiatives around the
world that use X-ray crystallography
or nuclear magnetic resonance (NMR)
spectroscopy attempting to determine
the three-dimensional (3-D) structures of one or more proteins from
each protein family with the goal of
predicting their function (4,5). While
computational methods of predicting
a protein’s 3-D structure based on its

sequence have dramatically improved
(6,7), a large number of proteins
remain whose sequences do not
show enough homology to known
structures to make structure predictions successful (8). In these cases,
sufficient amounts of the protein
must be expressed and purified prior
to acquisition of the requisite X-ray
crystallography or NMR spectroscopy
data. Arguably the rate-limiting step in
structural biology is in the production
of large amounts of proteins with high
enough quality for structural studies.
Current figures estimate that roughly
half of the proteins represented within
the human genome are expected to
be difficult to express or solubilize
(9–11).
Another area in which purified
proteins arising from the predicted
ORFs in the human genome would
have a tremendous impact is in the
generation of affinity reagents (12,13).

Array platforms for genomic analysis
are commonplace; however, their use
in proteomics has not been able to keep
pace due to the lack of high affinity
reagents for large numbers of proteins
found in the human proteome. While
antibodies can be generated against
synthetic peptides, the availability of
the native protein generally produces
reagents with greater specificity and
utility.
One of the bottlenecks in acquiring
a sufficient amount of purified protein
with which to conduct structural
studies or generate affinity reagents
is obtaining high levels of soluble
expression (9). Determining the
expression characteristics of a cloned
ORF in a specific system and under a
specific set of conditions is usually a
matter of trial and error (14,15). The
standard approach requires cloning
individual ORFs into an expression
vector, which is introduced into an
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Figure 1. Improved pooled open reading frame (ORF) expression technology (POET) method. The green boxes highlight improcxvements made to the
previous method that dramatically increase the throughput in recognizing clones that efficiently express using POET.

expression host, and then expressed
in separate cultures under a number of
different conditions such as induction,
time, and temperature. Those cultures
that show positive expression are
grown and induced at a scaled-up
level so that protein purification can
be attempted. While automation has
helped, the logistics and costs of
this high-risk strategy are enormous
when one considers the expression of
hundreds or thousands of ORFs.
We previously described a method
termed pooled ORF expression
technology (POET) that combines
recombinational cloning and collections of sequenced ORFs with
proteomic methods [two-dimensional
polyacrylamide gel electrophoresis (2D-PAGE) and tandem mass
spectrometry (MS/MS)] to predict
which ORFs in a pool will yield
soluble, purified protein (16). While
this method had a high success rate in
identifying which ORFs expressed high
levels of soluble protein, its overall
throughput was low. The bottleneck in
the procedure was the need to separate
the protein mixture using 2D-PAGE
prior to MS/MS identification of the
hundreds of visualized proteins spots.
In addition, Escherichia coli proteins
cannot be distinguished from those
expressed by the human ORFs using
2D-PAGE, resulting in a necessarily
308 ı BioTechniques ı www.biotechniques.com

high percentage of the experimental
time being devoted to identification
of host proteins. As described below,
we have dramatically improved the
throughput of POET by obviating the
need to quantify the expressed proteins
through visualization of a 2D-PAGE
gel. In this improved approach, the
relative abundance of the expressed
proteins is determined by calculating
their exponentially modified protein
abundance index (emPAI) (17) using
data acquired by direct reversed-phase
high-performance liquid chromatography-MS/MS (LC-MS/MS) analysis
of the expressed protein pool. As with
the previous study, a high percentage
of ORFs identified in this experiment
yielded expressed, soluble, purified
proteins in agreement with POET
predictions. The consistency of the
data in the nine replicates and the
simplicity of the method represent
a significant improvement over the
earlier POET protocol.
MATERIALS AND METHODS
ORF Pool
The Homo sapiens ORFeome
version 1 has been described previously (18). The DNA concentrations
of the 7864 Gateway entry clones used

in this experiment were determined
by PicoGreen (Molecular Probes,
Invitrogen, Carlsbad, CA, USA)
fluorescence and used to calculate the
molar concentration of each plasmid
(based on the size of each ORF and
the size of the pDONR223 backbone),
which ranged from 0 to 23.1 nM. All
wells containing <0.15 nM plasmid
concentration were omitted, leaving
7352 ORFs. These clones were
further subdivided into two classes
(“known” and “unknown”) based on
the following criteria: “unknowns”
must (i) have no predicted transmembrane domains, (ii) have no predicted
secretion signal sequence, and (iii)
have no structure of themselves or any
homolog in the Protein Data Bank.
We decided on 30% as the cutoff
for homology to produce a pool of
proteins of interest to researchers
that were reasonable likely to be
purifiable. This “unknown” pool
contained 3279 clones. The pool was
subdivided further into six subpools of
approximately 512 ORFs each, which
were set up to contain an even distribution of insert sizes. These pools
were designated U1 through U6, and
were concentration-normalized by
the method previously described for
the POET analysis of ORFs obtained
from Caenorhabditis elegans (16).
The pools were ethanol-precipitated
Vol. 45 ı No. 3 ı 2008
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Table 1. Proteins from Sample 1 (Run in Triplicate), with the Highest emPAI Scores Showing Individual Sample emPAI Score
Theoretical
Peptide Count

Protein

FKBP-type peptidyl-prolyl cis-trans isomerase slyD
Chaperone protein DnaK
Protein CGI-38
UPF0235 protein C15orf40
60 kDa Chaperonin (GroEL)
Ferric uptake regulation protein
Programmed cell death protein 5
Ribosomal small subunit pseudouridine synthase A
Developmental pluripotency associated 4
26S Proteasome subunit p27
Catabolite gene activator
Major outer membrane lipoprotein precursor (OmpF)
Hypothetical protein MGC43122
HCV NS5A-transactivated protein 9
KIAA1536 protein

21
177
70
36
146
39
45
54
90
57
61
22
37
39
190

Peptide
Count

emPAI
Scores

1a

1b

1c

1a

1b

1c

5
36
12
7
21
4
5
6
8
5
6
2
3
3
16

5
31
12
5
22
6
7
6
10
5
4
2
4
3
14

5
36
15
5
22
5
5
5
10
6
7
2
3
4
18

0.73020
0.59731
0.48398
0.56475
0.39263
0.26638
0.29155
0.29155
0.22713
0.22383
0.25418
0.23285
0.20526
0.19378
0.21398

0.73020
0.49672
0.48398
0.37686
0.41477
0.42510
0.43072
0.29155
0.29155
0.22383
0.16298
0.23285
0.28265
0.19378
0.18491

0.73020
0.59731
0.63789
0.37686
0.41477
0.34340
0.29155
0.23764
0.29155
0.27428
0.30243
0.23285
0.20526
0.26638
0.24377

Proteins representing cloned human open reading frames (ORFs) are shown in bold. emPAI, exponentially modified protein abundance index.

and dissolved in Tris-EDTA to a final
concentration of 5 ng/μL.
Protein Expression
A single pool containing 512
ORFs [as Gateway attL entry clones
(6)] was subcloned into pDest527
(T7 promoter, amino-terminal His 6
fusion) with LR Clonase (Invitrogen)
according to the manufacturer’s
instructions, except that the reaction
was allowed to proceed for 5 h at
30°C. Each of the 512 ORFs expressed
in this vector contained the sequence
MRSGSHHHHHHRSDITSLYKKAG
added to its amino end and
YPAFLYKVVISLAR added to its
carboxyl end due to the lack of the
native stop codon. Reaction products
were transformed into DH5α cells
(Invitrogen), and 1% of the SOC
expression mixture was plated on
ampicillin. The remaining 99% of the
expression mixture was added to 50
mL CircleGrow (QBiogene, Carlsbad,
CA, USA) containing ampicillin,
and after overnight growth at 37°C,
plasmid DNA was purified (Fast
Plasmid; Brinkmann, Westbury, NY,
USA). Approximately 100 ng pooled
expression plasmids were electroporated into E. coli Rosetta (DE3) strain
(Novagen, EMD Chemicals, San
Diego, CA, USA), which compenVol. 45 ı No. 3 ı 2008

sates for eukaryotic codons that
are rare in E. coli. The 1 mL SOC
expression mixture was diluted
into 50 mL CircleGrow (containing
100 μg/mL ampicillin) and grown
overnight at 37°C. The overnight
culture was diluted 1:100 into 1 L
CircleGrow (containing 100 μg/mL
ampicillin), grown at 37°C to an A600
of 0.5, and cooled to 16°C, at which
time protein expression was induced
by adding isopropyl 1-thio-β-Dgalactopyranoside to a final concentration of 0.5 mM. After 16 h at 16°C,
cells were harvested and frozen at
-80°C. For individual expression
of positive and negative clones,
individual ORFs were subcloned by
LR recombination into pDest527, and
expression clones were individually
transformed into E. coli Rosetta
(DE3) cells and induced under the
same conditions as above. Whole-cell
samples for gel electrophoresis were
generated by centrifugation of 0.05
optical density (OD) units of induced
cells, followed by freeze-thaw at
-80°C, treatment with 1 U benzonase
nuclease at 37°C for 15 min, and
addition of standard sodium dodecyl
sulfate PAGE (SDS-PAGE) buffers
and tris(2-carboxyethyl)phosphine
(TCEP). Soluble fractions were
generated by a mild detergent lysis
of 1 OD units of induced cells using

the Readypreps procedure (Epicentre
Biotechnologies, Madison, WI, USA).
All gel samples were analyzed by
SDS-PAGE using 4%–20% Criterion
gels (Bio-Rad Laboratories, Hercules,
CA, USA).
Protein Purification
Proteins were purified using
immobilized metal affinity chroma-
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Figure 2. SDS-PAGE analysis of 11 pooled open reading frame (ORF) expression technology
(POET) positives [high exponential modified protein abundance (emPAI) scores, lanes 1–11] and
negatives (emPAI scores equal to zero, lanes 12–22) from whole-cell extracts and soluble supernatants of induced small-scale cultures containing individual clones. The yellow dots indicate the positions of the stained protein band produced from expression of the individual cloned ORF. The numbering
of the gel lanes correspond to the ORFs listed in Tables 4 and 5.

tography (IMAC) as described previously (16). E. coli cell pastes were
resuspended using two volumes of
extraction buffer per gram of wet
weight to achieve a final concentration
of 20 mM sodium phosphate buffer,
pH 7.5, 100 mM NaCl, 5 mM MgCl2,
5% glycerol, 45 mM imidazole, and
complete protease inhibitor-EDTA
(Roche Applied Science, Indianapolis,
IN, USA) at one tablet/50 mL extract.
Cell extracts were treated with 0.5 mg/
mL lysozyme for 30 min and 1 U/mL
benzonase (Novagen) for an additional
20 min. Samples were sonicated to lyse
the cells, and the lysates was adjusted
to 500 mM NaCl. The lysate was
centrifuged at 111,000× g for 30 min,
filtered (0.45 μm, polyethersulfone
membrane), and applied at 0.6 mL/min
to 1 ml HisTrap columns (Amersham
Biosciences, Piscataway, NJ, USA)
equilibrated with extraction buffer in
500 mM NaCl and 45 mM imidazole
(binding buffer). The columns were
washed with binding buffer until the
levels of protein flowing through the
column reached base line. Bound
proteins were eluted with binding

buffer containing 500 mM imidazole
into 1 mL fractions, which were subsequently analyzed using SDS-PAGE.
The pools created from the IMAC
fractions were precipitated by adding
25% (v/v) trichloroacetic acid (TCA)
to a final concentration of 6% (v/v).
After vortex mixing, the samples were
incubated on ice for 5 min followed
by centrifugation at 16,100× g for 10
min. The supernatant was removed,
and the pellet incubated with ice-cold
acetone for 5 min on ice followed
by centrifugation at 16,100× g for 5
min. The supernatant was discarded,
and the pellet was dried for 2 min at
70°C. The pellet was finally dissolved
in solubilization buffer (8 M urea, 4%
CHAPS, 50 mM Tris, pH 8.5) at room
temperature to a concentration of 20
mg/mL and stored in 50 μL aliquots
at -80°C.
Sample Preparation and MS/MS
Analysis
The pooled samples were digested
with trypsin using 5 mM dithiothreitol
(DTT), 25 mM NH4HCO3, and 0.5 μg

Research Reports
sequencing-grade modified trypsin
(Promega, Madison, WI, USA). All of
the samples were desalted with C18 Zip
Tips (Millipore, Billerica, MA, USA)
following the manufacturer’s protocols
prior to MS analysis. Chromatographic
separations of desalted tryptic peptides
were conducted using nanocolumns
prepared in-house. A 75 μm inner
diameter × 360 μm outer diameter
× 10 cm–long fused silica capillary
column (Polymicro Technologies,
Phoenix, AZ, USA) with one end
flame-pulled to a fine tip (∼5- to 7-μm
orifice) was slurry-packed with 5 μm,
300-Å pore size C18 stationary phase
(Phenomenex, Torrance, CA, USA).
The reversed-phase separations
were performed by injecting 5 μL
sample per analysis. The columns were
connected via a stainless steel union to
an Agilent 1100 Nanoflow LC system
(Agilent Technologies, Palo Alto,
CA, USA), which was used to deliver
solvents A (0.1% HCOOH in water)

and B (0.1% HCOOH in CH3CN).
After the sample was injected, a 20
min wash with 98% mobile phase A
was used to flush any remaining salts
from the sample. Peptide elution was
accomplished using a linear gradient
of 2% mobile phase B to 42% solvent
B over 40 min with a constant flow
rate of 250 nL/min. The column was
flushed for 15 min with 98% mobile
phase B and re-equilibrated with 98%
mobile phase A prior to subsequent
sample loading.
The nanoflow reversed-phase
LC column was coupled online to
a LIT mass spectrometer (LTQ;
ThermoElectron, Thermo Fisher
Scientitic, San Jose, CA, USA) using
the manufacturer’s nanoelectrospray
source with an applied electrospray
potential of 1.7 kV and capillary
temperature of 160°C. The LIT mass
spectrometer was operated in a datadependent mode in which each full
MS scan was followed by five MS/MS

scans, where the five most abundant
peptide molecular ions detected from
the MS scan were dynamically selected
for five subsequent MS/MS scans
using a normalized collision-induced
dissociation (CID) energy of 35% and
a dynamic exclusion of 60 s to reduce
redundant selection of peptides. The
CID spectra were analyzed using
SEQUEST operating on a Beowulf
18-node parallel virtual machine
cluster computer (ThermoElectron,
Thermo Fisher Scientific, Waltham,
MA, USA) using a combined UniProt
nonredundant E. coli and human
proteome database (containing 43,137
protein sequences) downloaded
January 2006 (www.expasy.org).
Only peptides with conventional
tryptic termini (allowing for up to two
internal missed cleavages) possessing
delta-correlation scores (ΔCn) > 0.08
and charge state-dependent crosscorrelation (X
Xcorr) criteria as follows
were considered as legitimate identifi-

Table 2. Mean emPAI Scores Obtained from Three Separate POET Experiments
Protein
FKBP-type peptidyl-prolyl cis-trans isomerase slyD
Chaperone protein DnaK
Protein CGI-38
UPF0235 protein C15orf40
60 kDa Chaperonin (GroEL)
Ferric uptake regulation protein
Programmed cell death protein 5
Ribosomal small subunit pseudouridine synthase A
Developmental pluripotency associated 4
26S Proteasome subunit p27
Catabolite gene activator
Major outer membrane lipoprotein precursor (OmpF)
Hypothetical protein MGC43122
HCV NS5A-transactivated protein 9
KIAA1536 protein
Optineurin
Hypothetical protein MGC4504
Coiled-coil domain-containing protein 16
RNA-binding protein with multiple splicing
Drebrin-like protein
30S Ribosomal subunit protein S15
Bifunctional polymyxin resistance arnA protein
Hypothetical protein MGC20255
KIAA1143
Sperm surface protein Sp17

emPAI Scores
Exp 1

Exp 2

Exp 3

0.730 ± 0.000
0.564 ± 0.581
0.535 ± 0.089
0.440 ± 0.108
0.407 ± 0.013
0.345 ± 0.079
0.338 ± 0.080
0.274 ± 0.031
0.271 ± 0.037
0.241 ± 0.029
0.240 ± 0.071
0.233 ± 0.000
0.231 ± 0.045
0.218 ± 0.042
0.214 ± 0.029
0.210 ± 0.053
0.199 ± 0.000
0.197 ± 0.013
0.180 ± 0.065
0.178 ± 0.014
0.157 ± 0.083
0.136 ± 0.010
0.133 ± 0.035
0.129 ± 0.000
0.124 ± 0.033

0.804 ± 0.220
0.459 ± 0.057
0.363 ± 0.126
0.500 ± 0.056
0.386 ± 0.067
0.427 ± 0.084
0.435 ± 0.130
0.295 ± 0.110
0.292 ± 0.057
0.241 ± 0.029
0.338 ± 0.106
0.151 ± 0.071
0.183 ± 0.087
0.218 ± 0.042
0.214 ± 0.015
0.214 ± 0.015
0.152 ± 0.041
0.182 ± 0.022
0.076 ± 0.034
0.257 ± 0.083
0.075 ± 0.000
0.114 ± 0.010
0.144 ± 0.021
0.129 ± 0.046
0.034 ± 0.030

0.670 ± 0.104
0.415 ± 0.039
0.469 ± 0.056
0.670 ± 0.107
0.349 ± 0.000
0.151 ± 0.105
0.535 ± 0.121
0.238 ± 0.000
0.239 ± 0.080
0.208 ± 0.057
0.164 ± 0.044
0.237 ± 0.129
0.110 ± 0.039
0.082 ± 0.037
0.235 ± 0.056
0.159 ± 0.041
0.176 ± 0.041
0.125 ± 0.024
0.057 ± 0.058
0.161 ± 0.043
0.075 ± 0.000
0.077 ± 0.032
0.064 ± 0.000
0.056 ± 0.025
0.017 ± 0.030

emPAI, exponentially modified protein abundance index; POET, pooled open reading frame (ORF) expression technology.
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cations: >1.9 for +1 charged peptides,
>2.2 for +2 charged peptides, and >3.1
for +3 charged peptides.
Quantitation of Protein Abundance
The relative abundance of proteins
in the POET pooled was calculated
using emPAI as described previously
(17). In this method, the PAI value
for each protein is initially calculated
and then converted to a corresponding
emPAI score by raising 10 to the
power of PAI, then subtracting 1
(10PAI–1). The PAI value is determined
by dividing the number of experimentally identified peptide fragments
from an MS analysis by the total
number of possible observable peptide
fragments (Nobsvd/N obsvbl) for each
individual protein. The emPAI index
allows a quick and easy estimation of
total protein content by normalizing
the data to the number of theoretical
peptides in a mixture of proteins. The
emPAI values were calculated and
averaged over three separate LC-MS/
MS analyses of each of the three
samples of purified proteins obtained
from the expressed ORF pools (nine
replicates total).
RESULTS
We previously developed the POET
method as a procedure for finding
which ORFs in a pool of hundreds
of ORFs can be most efficiently
converted, by cloning, expression, and
purification, into their corresponding
recombinant proteins (16). By
combining n ORFs into a single pool,
tasks that need to be conducted for
each individual clone (transformation,
plating, colony picking, culture,
induction, lysis, assays of solubility,
and purification) are reduced n-fold.
Where the previous method was
lacking was in the need to quantitate
the expression levels of the individual
ORFs through the visualization of the
proteins separated using 2D-PAGE.
The throughput of this method was
severely compromised by the need
to conduct in-gel digestion and MS
identification of all of the visualized
spots. A significant portion of the
spots were identified as host E. coli
312 ı BioTechniques ı www.biotechniques.com

Table 3. Rank of Proteins by emPAI Value from Three Separated Experiments
Protein

emPAI Rank

FKBP-type peptidyl-prolyl cis-trans isomerase slyD
Chaperone protein DnaK
Protein CGI-38
UPF0235 protein C15orf40
60 kDa Chaperonin (GroEL)
Ferric uptake regulation protein
Programmed cell death protein 5
Ribosomal small subunit pseudouridine synthase A
Developmental pluripotency associated 4
26S Proteasome subunit p27
Catabolite gene activator
Major outer membrane lipoprotein precursor (OmpF)
Hypothetical protein MGC43122
HCV NS5A-transactivated protein 9
KIAA1536 protein
Optineurin
Hypothetical protein MGC4504
Coiled-coil domain-containing protein 16
RNA-binding protein with multiple splicing
Drebrin-like protein
30S Ribosomal subunit protein S15
Bifunctional polymyxin resistance arnA protein
Hypothetical protein MGC20255
KIAA1143
Sperm surface protein Sp17

Exp 1

Exp 2

Exp 3

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

1
3
7
2
6
5
4
9
10
12
8
18
15
14
13
22
17
16
29
11
32
23
19
20
69

2
5
4
1
6
16
3
8
7
11
13
9
19
26
10
15
12
17
40
14
28
27
35
41
111

emPAI, exponentially modified protein abundance index.

proteins and therefore contribute no
information concerning the expression
efficiency of the proteins within the
ORF pool. In the method presented in
this article (Figure 1), proteins purified
from a pool of 512 ORFs expressed
in E. coli are tryptically digested and
directly analyzed using LC-MS/MS.
From these data, emPAI scores are
calculated for each of the identified
proteins to obtain a measure of their
abundance. The pool of 512 ORFs
was expressed and purified in three
different experiments using the same
conditions, and each of these mixtures
was analyzed three times using the
sample preparation and LC-MS/
MS method described in the Sample
Preparation and MS/MS Analysis
section.
The 15 most abundant proteins
present within the mixture obtained
from the expressed and purified ORFs
based on the emPAI values determined in the triplicate analysis of the
first ORF pool are shown in Table 1.

As with our previous study that used
2D-PAGE to quantitate the proteins
prior to MS identification, SlyD,
DnaK, GroEL, and OmpF were among
the most abundant E. coli proteins.
The emPAI values for the top 15 most
abundant proteins are given for each
of three separate LC/MS analysis. The
reproducibility between analyses is
very good, resulting in similar emPAI
values for each experiment conducted
for a single POET pool. Included
in this table is the peptide count for
each protein identified in the three
separate LC/MS/MS experiments.
Since the peptide count along with
the theoretical peptide count is used
to calculate the emPAI values, their
reproducibility mirrors that of the
corresponding emPAI values.
Three completely separate experiments (i.e., expression, purification,
sample preparation, and LC-MS/
MS analysis) were conducted
using equivalent aliquots of the
512 ORF-containing POET pool.
Vol. 45 ı No. 3 ı 2008
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The mean emPAI values and their
associated standard deviations for the
25 most abundant proteins found in
the first POET experiment are listed
in Table 2. The reproducibility over
the three separate experiments is high,
and the standard deviations for the
mean emPAI values are low. While
some minor variances are observed
between the mean emPAI values for
individual proteins in the three experiments, this discrepancy is well within
the limits of the random selection of
peptide for sequencing that is seen in
data-dependent MS/MS analysis of
complex protein mixtures.
Each of the 25 proteins shown in
Table 2 was ranked based on their
emPAI values calculated from the
three separate POET experiments that
examined the same pool of 512 human
ORFs. As shown in Table 3, proteins
that ranked high in one experiment
also typically ranked high in the other
two experiments. For example, SlyD
ranked as either the first or second
most abundant protein based on emPAI
values in the three POET experiments.
Most of the proteins identified within
the 10 most abundant proteins in the
first experiment were also found
within the top 10 of the other two
experiments. These results highlight
the reproducibility in conducting such
studies to find the human clones that
express high levels of proteins using
this pooled method. One exception
was Sp17, which gave a relatively high
emPAI score in the first experiment,

but ranked 69 and 11 in experiments
two and three, respectively.
The ORFs corresponding to the
top 11 emPAI scores were individually subcloned to serve as positive
standards for individual expression.
In addition, 11 clones that were not
identified by LC-MS/MS among the
pools of soluble expressed proteins
were subcloned to serve as negative
controls. Subclones were generated in
pDest527, and each of the 22 clones
was individually expressed under
the same conditions as the POET
experiment. Whole-cell extracts
were prepared to identify expressed
proteins, and soluble fractions were
separated by mild detergent lysis.
Samples of these fractions were run
on SDS-PAGE gels, and the results
are shown in Figure 2. All 11 positive
clones (as identified by their emPAI
values) showed strong expression in
the whole-cell extracts, as shown in
Table 4. Of these, six showed high
levels of expression of soluble protein,
while three additional proteins showed
moderate levels of expressed soluble
protein. Of the remaining two, soluble
protein could be detected for one of
the proteins using Western blotting
analysis with an anti-His6 antibody,
and appreciable levels of soluble
protein could not be detected for the
other.
In the individual validation of
11 negative clones (Table 5), seven
showed expression, although as a
whole, levels were lower than those
observed for the positive clones. Four

negative clones showed no detectable
expression in Coomassie-stained gels.
Only one of the negative proteins was
observed in the soluble fraction by
Coomassie staining, with a low level
of a second protein being detectable
using Western blot analysis. The
remaining nine negative clones
showed no detectable soluble protein.
Taken together, these data argue for
the strong correlation of high emPAI
scores from the soluble POET pool
and solubility behavior in individual
expression experiments. These data
are also similar to the results obtained
in our previous study, suggesting
that the much more efficient and
high-throughput direct LC-MS/
MS approach using emPAI scores is
comparable in data quality to the more
laborious 2D-PAGE gel approach to
POET.
DISCUSSION
The current trend in biological
sciences is to develop methods that
collect large amounts of data in a
high-throughput manner. These trends
can be seen in genome sequencing,
messenger RNA (mRNA) array
analysis, and proteome characterization by MS. Unfortunately, the
optimization of protein expression
conditions has generally been limited
to trial and error studies in which
single clones are tested per experiment (9–11). While automation has
enabled multiplexing of these trial

Table 4. Individual Expression Characteristics of 11 Human Clones That Showed High Expression Levels Based on emPAI Values
Obtained in POET Experiment
ORF
Protein CGI-38
UPF0235 protein C15orf40
Programmed cell death protein 5
Development pluripotency-4
26S Proteasome subunit p27
HCV NS5A-transactivated protein-9
KIAA1536 protein
Optineurin
Hypothetical protein MGC4504
Coiled-coil domain containing 16
Debrin-like protein

ORF ID
BC000691
BC019820
BC015519
BC032846
BC002383
BC007101
BC003177
BC013876
BC019625
BC011584
BC011667

emPAI
0.456
0.537
0.436
0.267
0.230
0.173
0.221
0.166
0.176
0.168
0.199

Expressed?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Soluble?
Good
Good
Good
Good
Good
Fair
Fair
Western
No
Fair
Good

Figure 2 Gel Lane
1
2
3
4
5
6
7
8
9
10
11

The final column indicates the lane in the gel shown in Figure 2. ORF, open reading frame; POET, pooled ORF expression technology; emPAI, exponentially modified protein abundance index.
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and error methods, the liquid handling
apparatus required to conduct such
endeavors is outside of the budget of
most laboratories. POET is designed
to provide a high-throughput method
to simultaneously screen hundreds
of ORFs to determine which clones
express reasonable amounts of recombinant proteins under a specific set of
cloning, expression, and purification
conditions. POET is not designed
to provide a complete quantitative
assessment of every clone in a given
pool, as there will undoubtedly be
some ORFs that do not express any
detectable level of protein. We have
previously demonstrated the utility
of combining hundreds of ORFs
into a single expression system.
Identification of clones that produced
high levels of recombinant protein
was hampered, however, by the need
to quantitate by staining 2D-PAGE
separated proteins (16). This need
directly leads to the major rate-limiting
step; coring out each individual protein
spot, subjecting it to in-gel digestion,
followed by identification using
LC-MS/MS. In addition, considerable
MS sample preparation and analysis
time is wasted on the identification
of E. coli host proteins, since these
proteins are not distinguishable prior
to MS analysis. The new, improved
method presented in this paper uses
a single LC-MS/MS analysis of the
entire purified POET pool. Relative
abundance is calculated directly by
comparing the number of experimentally identified peptides to the number
of theoretically observable peptides for
each individual protein. This method
essentially reduces the time required
to identify highly expressing human
clones by 1/n (where n is the number
of visualized protein spots) compared
with the previous method that required
visualization of 2D-PAGE separated
proteins. Unfortunately, using a
single dimension of separation prior
to MS analysis limits the number of
peptides that can be detected within
a given pool. Using multidimensional
chromatography, however, not only
increases the analysis time but renders
the results incompatible with emPAI
calculations.
Overall, there is good correlation
between an ORFs emPAI value calcu314 ı BioTechniques ı www.biotechniques.com

lated from the LC-MS/MS data and
its ability to be expressed in a soluble
form. Only one of the 11 clones,
hypothetical protein MGC4504, which
was predicted to provide a high level
of soluble protein based on its emPAI
value, failed to do so in the validation
study of individual clones. While the
reason for this discrepancy is not clear,
it should be recognized that pools of E.
coli cells each containing a different
ORF grow in competition with each
other. Any slowing of growth caused
by expression of an ORF will result
in underrepresentation of the corresponding protein in the purified pool.
A comparison of the entire list of
emPAI values (see Supplementary
Table S1 available online at www.
BioTechniques.com) shows that the
ratio of human to E. coli proteins is
approximately 3-fold higher in the
bottom 50 percentile of all proteins
that generated an emPAI value (c.f.,
6.4 to 2.3). The reason for, or the
statistical relevance of, this difference
is not obvious. It may be related to the
fact that the 512 cloned human ORFs
are under the control of an inducible
vector, whereas the E. coli proteins
are internally regulated based on the
needed response by the organism.
While E. coli may require a large
number of proteins to be expressed for
survival under the growth conditions
used in this study, low levels of most
of these proteins may be sufficient.
One drawback to the POET
approach is that multiple proteins are
likely being expressed in the same E.
coli cell, meaning that a protein could
potentially be stabilized by an interaction with another ORF. Conditions
of higher stress in the POET pool
could also lead to upregulation of
chaperones, which might also assist
in the soluble production of some
proteins. The single negative clone
that when individually expressed
made considerable soluble protein,
may be due to a pooling error, as the
original POET pools were manually
assembled.
The ability to screen a large
number of cloned ORFs in a single
high-throughput experiment opens up
a number of opportunities in structural
proteomics. For instance, interesting
proteins, such as those classified as

hypothetical that have no apparent
homology to known proteins, can be
prepared in a single pool and their
expression efficiency quickly determined. Functionally related pools (e.g.,
kinases, phosphatase, transcription
factors) can also be created, and their
recombinant expression tested. POET
can also be used in combination with
Gateway technology as a filtering
tool to determine the best expression
vector for individual ORFs. For
example, a pool of 500 ORFs could
be cloned into multiple different
vectors and expressed, purified, and
analyzed directly by LC-MS/MS.
The emPAI values calculated from
each experiment would then indicate
the optimal vector for each ORF.
The same principle could be used to
optimize the expression conditions
(e.g., temperature, induction time) for
pools of cloned ORFs.
While the quantitation of the
protein’s relative abundance using
a direct LC-MS/MS and emPAI
approach represents a major
improvement over the previous POET
method that required 2D-PAGE/
staining, there are still other areas that
can be improved upon. For example,
this study analyzed a pool of 512
cloned ORFs, while our previous study
analyzed a pool containing 688. The
effect that each recombinant protein
may have on the expression of another
cannot be easily determined in our
study. Therefore, optimization of the
number of cloned ORFs that can be
most effectively analyzed in a single
pool using POET needs to be determined. While conventional thinking is
to make the pools as large as possible
to increase the number of positive
expressors found per experiment,
large pools may have an adverse
effect on the host machinery, thereby
hampering efficiency. Analysis of
smaller pools of ORFs may ultimately
be a more efficient method, as it may
minimize the effect of recombinant
protein perturbation on the host cell.
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